The CEO Roundtable on Cancer has accredited PAREXEL International in Waltham, MA with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer, a nonprofit organization of CEOs, founded by former President George H.W. Bush, developed and administers the Gold Standard, an employee wellness framework based on taking concrete actions in five key areas to address cancer in the workplace. Nearly 200 private, nonprofit and government employers in a wide range of occupational categories have earned Gold Standard accreditation, including the National Cancer Institute (NCI) and a number of NCI-designated cancer centers.
“Our CEO Cancer Gold Standard certification further demonstrates that PAREXEL International is a unique organization committed to improving individuals’ lives and that that commitment begins with improving the health of the company’s employees and their family members,” said Christopher A. Viehbacher, chairman of the CEO Roundtable on Cancer.
To earn Gold Standard accreditation, an employer must establish programs to reduce cancer risk by taking concrete actions in five key areas: establishing policies and programs to reduce cancer risk by prohibiting tobacco use and supporting tobacco cessation efforts; promoting physical activity, healthy nutrition and weight management; providing health insurance options that include detecting cancer at its earliest stages, access to quality care and participation in cancer clinical trials; promoting employee awareness of these initiatives; and supporting the needs of cancer survivors in the workplace.
“At PAREXEL, we have a passion for making a profound difference in the lives of people – especially our employees and their families,” said Josef von Rickenbach, Chairman and CEO, PAREXEL. “We are honored the CEO Roundtable on Cancer named us a Gold Standard employer, recognizing our commitment to the health and well-being of our most important asset: our employees.”
In addition to NCI and the Centers for Disease Control and Prevention, 16 NCI-designated cancer centers and more than 60 other hospitals have earned Gold Standard accreditation. CEOs from many industries are keenly aware of the life-improving impact they can have on health and controlling healthcare costs when they address cancer and other chronic diseases. Gold Standard employers include: Avis Budget Group, Harvard T.H. Chan School of Public Health, Lowe’s, Aetna, State Farm, Hogan Lovells, Dell, Johnson & Johnson, Novartis, SAS and many Blue Cross affiliates.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 80 locations in 51 countries around the world, and had approximately 18,660 employees in the fourth quarter. For more information about PAREXEL International visit www.PAREXEL.com.
PAREXEL and PAREXEL Informatics are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates.